R. Aziza

1.1k total citations
49 papers, 617 citations indexed

About

R. Aziza is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, R. Aziza has authored 49 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Rheumatology. Recurrent topics in R. Aziza's work include Prostate Cancer Diagnosis and Treatment (15 papers), Prostate Cancer Treatment and Research (14 papers) and MRI in cancer diagnosis (9 papers). R. Aziza is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (15 papers), Prostate Cancer Treatment and Research (14 papers) and MRI in cancer diagnosis (9 papers). R. Aziza collaborates with scholars based in France, Switzerland and Italy. R. Aziza's co-authors include F. Joffre, Marie‐Bernadette Delisle, B Mazières, Michel Laroche, Bernard Malavaud, M Salvador, P Bernadet, B Chamontin, A. Benlyazid and Jérôme Sarini and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Spine.

In The Last Decade

R. Aziza

44 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Aziza France 14 355 158 152 109 80 49 617
Shinsuke Sugihara Japan 14 247 0.7× 232 1.5× 203 1.3× 37 0.3× 37 0.5× 65 603
Hiroatsu Nakashima Japan 17 453 1.3× 347 2.2× 219 1.4× 181 1.7× 61 0.8× 33 789
Yoji Shido Japan 10 262 0.7× 227 1.4× 123 0.8× 197 1.8× 56 0.7× 29 515
Anthony Ciarallo Canada 13 271 0.8× 55 0.3× 130 0.9× 87 0.8× 239 3.0× 47 664
Laurette Renard Belgium 12 402 1.1× 321 2.0× 198 1.3× 88 0.8× 196 2.5× 21 885
J. Manuel Sarmiento United States 13 175 0.5× 59 0.4× 119 0.8× 81 0.7× 49 0.6× 35 520
Massimo Eraldo Abate Italy 16 449 1.3× 188 1.2× 156 1.0× 131 1.2× 22 0.3× 39 780
S A Sohaib United Kingdom 12 154 0.4× 102 0.6× 226 1.5× 87 0.8× 189 2.4× 20 642
Ayoub Nahal Canada 13 333 0.9× 279 1.8× 133 0.9× 21 0.2× 60 0.8× 47 620
Jamie T. Caracciolo United States 13 171 0.5× 305 1.9× 166 1.1× 53 0.5× 42 0.5× 33 665

Countries citing papers authored by R. Aziza

Since Specialization
Citations

This map shows the geographic impact of R. Aziza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Aziza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Aziza more than expected).

Fields of papers citing papers by R. Aziza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Aziza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Aziza. The network helps show where R. Aziza may publish in the future.

Co-authorship network of co-authors of R. Aziza

This figure shows the co-authorship network connecting the top 25 collaborators of R. Aziza. A scholar is included among the top collaborators of R. Aziza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Aziza. R. Aziza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ploussard, Guillaume, Éric Barret, G. Fiard, et al.. (2024). Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). European Urology Oncology. 7(5). 1080–1087. 35 indexed citations
2.
Péricart, Sarah, R. Aziza, D. Portalez, et al.. (2023). Significant prostate cancer risk after MRI-guided biopsy showing benign findings: Results from a cohort of 381 men. PubMed. 34(1). 102547–102547.
3.
Pigneur, F., Mario Di Palma, Bruno Raynard, et al.. (2023). Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia. Journal of Cachexia Sarcopenia and Muscle. 14(4). 1613–1620. 18 indexed citations
4.
Cabarrou, Bastien, R. Aziza, Eva Jouve, et al.. (2022). Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes. The Breast. 67. 102–109. 5 indexed citations
5.
Aziza, R., C. Chira, Eva Jouve, et al.. (2021). Diagnosis, biology and epidemiology of oligometastatic breast cancer. The Breast. 59. 144–156. 6 indexed citations
6.
7.
Beauval, Jean‐Baptiste, M. Lesourd, C. Alméras, et al.. (2020). MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy. Journal of Clinical Medicine. 9(12). 3841–3841. 18 indexed citations
8.
Chira, C., R. Aziza, Eva Jouve, et al.. (2020). 320P Oligometastatic breast cancer incidence and clinical presentation at diagnosis: About 131 cases. Annals of Oncology. 31. S371–S371. 1 indexed citations
9.
Roumiguié, M., M. Lesourd, Christophe Tollon, et al.. (2020). Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features. Urologic Oncology Seminars and Original Investigations. 38(5). 386–392. 4 indexed citations
10.
Roumiguié, M., M. Lesourd, Jean‐Baptiste Beauval, et al.. (2020). Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions. Urologic Oncology Seminars and Original Investigations. 38(9). 734.e11–734.e17. 1 indexed citations
11.
Ploussard, Guillaume, Jean‐Baptiste Beauval, M. Lesourd, et al.. (2019). Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study. World Journal of Urology. 38(7). 1735–1740. 5 indexed citations
12.
Ploussard, Guillaume, Jean‐Baptiste Beauval, M. Lesourd, et al.. (2019). Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies. Urology. 137. 126–132. 9 indexed citations
13.
Roumiguié, M., P. Gräff, Jonathan Khalifa, et al.. (2018). Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies. World Journal of Urology. 37(2). 269–275. 12 indexed citations
14.
Massabeau, Carole, Jonathan Khalifa, Thomas Filleron, et al.. (2017). Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non–Small-cell Lung Cancer: A Phase I Study. Clinical Lung Cancer. 19(3). e277–e285. 21 indexed citations
15.
Ravaud, Alain, Carlos Gomez‐Roca, Marie-Quitterie Picat, et al.. (2017). Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study. European Journal of Cancer. 85. 39–48. 2 indexed citations
16.
Fuzier, Régis, et al.. (2016). Even a “pigtail” distal end catheter can enter the epidural space after continuous paravertebral block. Journal of Anesthesia. 30(3). 503–505. 1 indexed citations
17.
Benlyazid, A., et al.. (2007). Ameloblastic carcinoma of the maxilla: case report and review of the literature. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 104(6). e17–e24. 69 indexed citations
18.
Aziza, R., et al.. (2001). Evaluation de la qualité du dossier du patient à l'Institut Claudius-Regaud. Bulletin du Cancer. 88(8). 793–803. 2 indexed citations
19.
Aziza, R., et al.. (2001). Assessing the quality of Claudius-Regaud Institute patients' medical records. Bulletin du Cancer. 88(8). 793–803.
20.
Joffre, F., et al.. (1994). Renal artery stent placement: long-term results with the Wallstent endoprosthesis.. Radiology. 191(3). 713–719. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinsuke Sugihara Breakdown of academic impact, for papers by Hiroatsu Nakashima Breakdown of academic impact, for papers by Yoji Shido Breakdown of academic impact, for papers by Anthony Ciarallo Breakdown of academic impact, for papers by Laurette Renard Breakdown of academic impact, for papers by J. Manuel Sarmiento Breakdown of academic impact, for papers by Massimo Eraldo Abate Breakdown of academic impact, for papers by S A Sohaib Breakdown of academic impact, for papers by Ayoub Nahal Breakdown of academic impact, for papers by Jamie T. Caracciolo
Rankless by CCL
2026